Pharmacoepidemiology and Drug Safety

Cover image for Pharmacoepidemiology and Drug Safety

January/February 1994

Volume 3, Issue 1

Pages fmi–fmi, i–ii, 1–60

  1. Masthead

    1. Top of page
    2. Masthead
    3. Editorial
    4. Samm Guidelines and Commentary
    5. Commentary on the Samm Guidelines
    6. Special Report
    7. Original Reports
    8. Letter to the Editor
    9. Book Review
    10. Current Awareness
    1. Masthead (page fmi)

      Version of Record online: 12 JAN 2006 | DOI: 10.1002/pds.2630030101

  2. Editorial

    1. Top of page
    2. Masthead
    3. Editorial
    4. Samm Guidelines and Commentary
    5. Commentary on the Samm Guidelines
    6. Special Report
    7. Original Reports
    8. Letter to the Editor
    9. Book Review
    10. Current Awareness
    1. Editorial (pages i–ii)

      R. D. Mann

      Version of Record online: 12 JAN 2006 | DOI: 10.1002/pds.2630030102

  3. Samm Guidelines and Commentary

    1. Top of page
    2. Masthead
    3. Editorial
    4. Samm Guidelines and Commentary
    5. Commentary on the Samm Guidelines
    6. Special Report
    7. Original Reports
    8. Letter to the Editor
    9. Book Review
    10. Current Awareness
  4. Commentary on the Samm Guidelines

    1. Top of page
    2. Masthead
    3. Editorial
    4. Samm Guidelines and Commentary
    5. Commentary on the Samm Guidelines
    6. Special Report
    7. Original Reports
    8. Letter to the Editor
    9. Book Review
    10. Current Awareness
  5. Special Report

    1. Top of page
    2. Masthead
    3. Editorial
    4. Samm Guidelines and Commentary
    5. Commentary on the Samm Guidelines
    6. Special Report
    7. Original Reports
    8. Letter to the Editor
    9. Book Review
    10. Current Awareness
  6. Original Reports

    1. Top of page
    2. Masthead
    3. Editorial
    4. Samm Guidelines and Commentary
    5. Commentary on the Samm Guidelines
    6. Special Report
    7. Original Reports
    8. Letter to the Editor
    9. Book Review
    10. Current Awareness
    1. Antidepressant drug use in an ambulatory elderly population: A 14-year overview (pages 23–29)

      Ronald B. Stewart, Ronald G. Marks, Phillip D. Padgett and William E. Hale

      Version of Record online: 12 JAN 2006 | DOI: 10.1002/pds.2630030107

    2. Adverse drug reactions in HIV seropositive patients (pages 31–40)

      Dr C. Benichou, M. Eliaszewicz and A. Flahault

      Version of Record online: 12 JAN 2006 | DOI: 10.1002/pds.2630030108

  7. Letter to the Editor

    1. Top of page
    2. Masthead
    3. Editorial
    4. Samm Guidelines and Commentary
    5. Commentary on the Samm Guidelines
    6. Special Report
    7. Original Reports
    8. Letter to the Editor
    9. Book Review
    10. Current Awareness
    1. Calcitonin and epistaxis (pages 41–42)

      Pilar Alvarez, Albert Figueras, Dolors Capella and Joan-Ramon Laporte

      Version of Record online: 12 JAN 2006 | DOI: 10.1002/pds.2630030109

  8. Book Review

    1. Top of page
    2. Masthead
    3. Editorial
    4. Samm Guidelines and Commentary
    5. Commentary on the Samm Guidelines
    6. Special Report
    7. Original Reports
    8. Letter to the Editor
    9. Book Review
    10. Current Awareness
  9. Current Awareness

    1. Top of page
    2. Masthead
    3. Editorial
    4. Samm Guidelines and Commentary
    5. Commentary on the Samm Guidelines
    6. Special Report
    7. Original Reports
    8. Letter to the Editor
    9. Book Review
    10. Current Awareness

SEARCH

SEARCH BY CITATION